Healthcare leaders speaking at AXS26 argued that artificial intelligence tools affecting patient care require stronger oversight, including independent validation, bias monitoring, and human review. The discussion highlighted both operational opportunities and safety concerns surrounding healthcare AI adoption.

Attorneys speaking at a specialty pharmacy meeting warned that increased federal attention to fraud, waste, abuse, controlled substances, and reimbursement practices is driving greater scrutiny of pharmacies. The discussion focused on compliance preparedness rather than new regulatory requirements.

The FDA classified a recall of thyroid tablets USP 30 mg as Class I after identification of a superpotent product lot. The recall affects 1,955 bottles and carries risk of serious adverse health consequences, making prompt inventory review and product removal necessary.

A novel liposomal drug-delivery system prolonged tetrodotoxin nerve blockade to two to three weeks in rats, substantially exceeding currently available formulations. The findings highlight a potential strategy for sustained local anesthetic delivery, although clinical relevance remains unproven pending human validation.

Analysis of NVDRS data identified 1,577 nurse and nursing assistant homicide victims between 2003 and 2022, with most deaths occurring in private residences and frequently involving intimate partners or ex-partners rather than workplace violence.

With US measles cases reaching their highest levels in decades, a nursing-focused CE review summarizes current evidence on epidemiology, clinical presentation, complications, infection control, and critical care management of pediatric measles amid declining vaccination rates.